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Antibody has been postulated to regulate its production through a feedback
mechanism, which modulates the amount of antigen available in immunogenic
form (1). However, new antibody synthesis may occur even in the presence of a
large excess of circulating antibody, e.g., after secondary immunization or after
reduction of serum antibody levels by exchange transfusion or immunoadsorb-
ants (2-4). Since stimulation of B cells to antibody-secreting cells requires the
interaction of antigen with specific cell surface binding sites, these findings
suggest that immune cells are able to capture antigen even in the presence of a
large excess of antibody .
Earlier studies have demonstrated that cells of the murine plasmacytoma
MOPC 315 have surface immunoglobulin (Ig) with specificity for DNP (5) and
also secrete into the serum of animals bearing this tumor an IgA which binds
DNP with moderate affinity (6, 7). Thus MOPC 315 cells are analogous to normal
B cells in having on their surface Igwhich will specifically bind antigen. We have
used DNP conjugates and MOPC 315 cells as a model system to study the
energetics of interaction of antigen with specific binding sites on immunocytes
(5).
In the presentreport this system has been used to examine the abilityofcells to
compete with free antibody for antigen. The binding of radiolabeled multivalent
and univalent DNP conjugates to MOPC 315 cells was measured in the presence
of various concentrations of serum obtained from mice bearing this tumor. The
data reported here indicate that free specific Ig will compete with cell surface
binding sites for antigen, and that binding of a multivalent conjugate to cells is
favored over its binding to Ig. Thus, immunocytes can effectively interact with,
and specifically bind, antigen even in the presence of a large excess of free Ig of
similar specificity.
Materials and Methods
Source andPreparation of Cells.
￿
The murine plasmacytomas, MOPC 315(obtained from Dr. M.
Potter, National Institutes of Health, Bethesda, Md.) and HP 76 (obtained from Dr. Noel Warner,
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Walter and Eliza Hall Institute, Melbourne, Australia), were carried by serial transplantation in
female BALB/c mice . Single cell suspensions were prepared as previously described (5) .
Antigens . Dinitrophenylated bovine serum albumin (DNP-BSA)' and N-2,4-dinitrophenyl-E-
amino-N-caproic acid (DNP-EACA) were prepared as previously described (5, 8) . There were
approximately 23 DNP groups per molecule ofDNP-BSA based upon its absorbancy at 360 nm when
e=17,500 for DNP-lysine . DNP-BSAwas radiolabeled by lactoperoxidase-catalyzed iodination (9) to
asp act of 5-10 x 10 5 cpm/lAg. Tritiated DNP-EACA wasprepared by the reaction of ['H]1-fluoro-2,4-
dinitrobenzene (DNFB) (Amersham/Searle Corp ., Arlington Heights, Ill .) with EACA (5, 10) . Sp act
was 2 x 10 5 cpm/gg.
Antisera .
￿
MOPC 315serumwas obtained from BALB/c female mice 3 wk after the inoculation of
10 8 viable MOPC 315 cells . The number of binding sites for DNP in this serum was 2 x 10'8/ml by
equilibrium dialysis (performed by Dr . Young Tai Kim, Department of Medicine, Cornell University
Medical College, New York) . Control mouse serum was collected from normal female BALB/c mice .
Antisera to BSA was prepared by four weekly subcutaneous injections of 0.5 mg of purified BSA into
guinea pigs .
Binding ofDNP Conjugates to Cells .
￿
Duplicate or triplicate 0.1-ml aliquots of undiluted normal
mouse serum or of serial dilutions ofMOPC 315serum in normal mouse serum were incubated for 2
min with [' 251]DNP-BSA (2 x 10 - 'z mol) or with ['H]DNP-EACA (4 x 10 -" mol) in a final vol
brought up to 0.6 ml with phosphate-buffered saline (PBS) . 8 x 10 5 MOPC 315 or HP 76 cells in 0.1
ml of PBS were added and incubated for 30 min at room temperature . [' 111]DNP-BSA binding was
studied in the presence of a final concentration of 5% BSA (Pentex, Miles Laboratories, Inc ., Miles
Research Div., Kankakee, Ill .) . Cells were washed with 2 ml ofPBSthree times forDNP-BSA-bind-
ing studies, and once for studies with DNP-EACA .
Cell-bound radioactivity was measured as previously described (5), and the amount of cell-bound
DNP conjugate was calculated from its specific activity . Specific binding was calculated by
subtracting from the amount ofDNPconjugate bound to MOPC 315 cells that bound nonspecifically
to control murine myeloma cells (HP-76) .
Results
Effect of Specific Ig on Binding of [1257]DNP-BSA to Cells .
￿
To determine the
effect of specific Ig on the binding of a multivalent antigen to immunocytes, the
binding of [1251]DNP-BSA to MOPC 315 or control cells was studied in the
presence of increasing concentrations of MOPC 315 or normal mouse serum . The
results of a representative experiment are shown in Fig . 1 . In the presence of
normal mouse serum, MOPC 315 cells bound approximately 10 times more
[ 1251]DNP-BSA than did control cells . High concentrations of MOPC 315 serum
inhibited total and specific binding of the conjugate to MOPC 315 cells . The
highest concentration of MOPC 315 serum inhibited specific binding by over
90% . Similar findings were obtained in two additional experiments . MOPC 315
serum increased binding of DNP-BSA to control cells and, at low concentrations,
to MOPC 315 cells . Low concentrations of MOPC 315 serum increasedbinding of
DNP-BSA to control cells in all of three experiments, and to MOPC 315 cells in
four of five experiments . Though the percentage increase in [ 1251]DNP-BSA
binding caused by MOPC 315 serum was greater with control cells, the absolute
increase in the average amount of this antigen bound to each cell type was very
similar : 2.38 x 10-21 mol/MOPC 315 cell and 2.13 x 10-2 1 mol/HP 76 cell .
Quantitative Relationship between Antigen Binding to Cells and Concentra-
tion of Free Ig, Antigen, and Cell Surface Binding Sites .
￿
Fig. 2 illustrates the
Abbreviations used in this paper : BSA, bovine serum albumin ; DNFB, 1-fluoro-2,4-dinitroben-
zene ; DNP-BSA, dinitrophenylated bovine serum albumin ; EACA, E-amino-N-caproic acid ; PBS,
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Effect ofMOPC 315 or normal mouse sera on binding of [I'll]DNP-BSA toMOPC 315
or control cells . Fixed amounts oftheconjugate (2 x 10- 'z mol) were incubatedwith increasing
concentrations ofMOPC 315 or normal mouseserum for2 min and with asimilar number of
MOPC 315 or control cells (8 x 10') for 30 min. In this experiment therewas no augmentation
of [1151]DNP-BSA binding to MOPC 315 cells in the presence of low concentrations ofMOPC
315 serum .
Free/Cell SurfaceDNP-Binding Sites
FIG. 2 .
￿
Inhibition of specific binding of ['III]DNP-BSA toMOPC 315 cells as afunction of the
ratio of specific antibody to cell surface DNP-binding sites . Percent inhibition of specific
binding was calculated from :
specific binding toMOPC 315 cells in presence ofMOPC 315serum
(1
￿
) specific binding toMOPC 315 cells in presence of normal serum
￿
x 100'
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ability of cell surface DNP-binding sites to compete with DNP-binding sites on
free Ig for DNP-BSA . The data were calculated from the average of the
experiments described above, and from earlier studies indicating that there were
8.4 x 10 4 binding sites forDNP-BSA perMOPC 315 cell (5) and 2 x 10' 6 binding
sites for DNP per ml of undiluted MOPC 315 serum . The concentration of
DNP-BSA used bound approximately 30% of available cell surface binding sites
for this conjugate . 90 binding sites on free Ig were required per cell surface1230
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binding site to inhibit by 50% specific binding of the conjugate to cells. Specific
binding of conjugate to cells still occurred with a 30,000-fold excess of free to cell
surface binding sites . On the basis of two binding sites per MOPC 315 IgA
molecule, 3.8 x 10 6 Ig molecules per cell were required for 50% inhibition of
DNP-BSA binding and specific binding still occurred with an excess of 1 .25 x 109
Ig molecules per MOPC 315 cell . Thus, cells can compete very effectively with
serum Ig for antigen and can specifically bind significant quantities of antigen
despite the presence of a large excess of free specific Ig .
Effect of Anticarrier Antibody on Binding of DNP-BSA to Cells . Since
hapten-specific Ig can increase binding of DNP-BSA to control or MOPC 315
cells, studies were conducted to investigate the effect of antibody to carrier . A
fixed amount of [ . ..I]DNP-BSA (2 x 10-12 mol) was mixed with increasing
concentrations of guinea pig anti-BSA serum orMOPC 315 serum for 2 min and
with a similar number of MOPC 315 or control cells for 30 min . In two such
experiments, anti-BSA serum consistently augmented by 20-90% total binding of
11251JDNP-BSA to control cells, but did not augment binding to MOPC 315 cells .
As a consequence, anti-BSA serum slightly decreased (approximately 15%) the
calculated specific binding to MOPC 315 cells . The increased amount of
conjugate bound to control cells in the presence of anti-BSA serum averaged 2 .2
x 10 -21 mol per HP 76 cell, an increase similar to that occurringwithMOPC 315
serum .
Effect of Time of Incubation . Earlier studies have shown that specific
binding ofDNP conjugates to MOPC 315 cells increases with time of incubation
(5). The effect of this variable on antigen binding to these cells in the presence of
specific Ig was tested . 0.5 ml of [" 5I]DNP-BSA (5 x 10-12 mol) was preincubated
with 0.5 ml of undiluted MOPC 315 or normal mouse serum for 30 min to mimic
the in vivo situation where antigen most likely interacts with antibody before
reacting with cells . 12 million MOPC 315 or control myeloma cells were added in
3 ml ofPBS, and duplicate 0.2-ml aliquots of the resulting suspension assayed at
several time intervals thereafter . Under the conditions of this experiment, the
ratio of free to cell surface binding sites was 10,000 to 1 . As can be seen in Table 1,
specific binding of [1211JDNP-BSA toMOPC 315 cells occurred within 30 s in the
presence of normal mouse serum, and increased thereafter . MOPC 315 serum
completely inhibited specific binding of the conjugate initially, but specific
binding did occur after 30 min and increased slowly thereafter . Thus a prolonged
period of time is required to establish equilibrium.
Effect of Specific Ig on Binding of Univalent Conjugate to Cells .
￿
The effect of
specific Ig on the binding of the univalent conjugate [3H]DNP-EACA to MOPC
315 cells was determined as described above with [' 25I]DNP-BSA, except that
BSA was omitted and the cells were washed only once with PBS . Prior studies
had indicated these modifications were necessary to obtain optimal specific
binding of this ligand to MOPC 315 cells (5) . The result of a representative
experiment is shown in Fig . 3 . In the presence of normal mouse serum, MOPC
315 cells bound approximately three times more [3H]DNP-EACA than did
control cells . Increasing concentrations of MOPC 315 serum decreased total
binding to both MOPC 315 and control cells . However, binding to MOPC 315
cells was decreased to a greater extent than to control cells . At the highest serumJEAN-CLAUDE BYSTRYN,GREGORY W.SISKIND,JONATHAN W. UHR
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TABLE I
Effect of Incubation Time on Binding of DNP-BSA to MOPC 315 Cells in Presence of
Specific Ig
§ Averageamount [115I]DNP-BSAbound to duplicate aliquots of 6 x 10 5 cells incubated with 5 x 10 - '2
mol of the conjugate in 4 ml PBS.
Calculated by subtracting moles [ 1 z5I]DNP-BSAbound toHP 76 cells from amount [' 25I]DNP-BSA
bound to MOPC 315 cells .
Undiluted
Normal
Mouse
Serum
Amount of ['zII]DNP-BSA (10-" moles) bound to cells§
10-6 10-4 10-2 Undiluted
Dilution MOPC 315 Serum
FIG. 3 .
￿
Effect ofMOPC 315 or normal serum on binding of [eH]DNP-EACA toMOPC 315 or
control cells . Fixed amounts of [3H]DNP-EACA (4 x 10-1 ' mol) were incubated with
increasing amounts ofMOPC 315 or with normal mouse serum for 2 min, and with a similar
number of MOPC 315 or control cells (8 x 10 5) for 30 min .
concentration, specific binding was inhibited by 74% . No consistent enhance-
ment of total or specific binding toMOPC 315 or to control cells was observed at
any dilution of MOPC 315 serum .
Fig. 4 illustrates the ability of cell surface DNP-binding sites to compete with
DNP-binding sites on free Ig for DNP-EACA . On the basis of there being 1 .1 x
10' binding sites for DNP-EACA per MOPC 315 cell and the amount of
DNP-EACA andMOPC 315 serum used, 40 binding sites on free Igwere required
per cell surface site to inhibit specific binding of DNP-EACA by 50%.
Total Specific
Sera*
Time of incubation
Cells$
. . . . . . . . . . . . . . . .
0.5
min
5
min
30
min 24 h 0.5
min
5
min
30
min 24 h
MOPC 315 MOPC 315 0.14 0.17 0.40 0.54 0 0 0.17 0.26
MOPC 315 HP 76 0.18 0.17 0.23 0.28
Normal MOPC 315 0.54 0.75 1.42 2.09 0.37 0.53 1.19 1.74
Normal HP 76 0.17 0.22 0.23 0.35
*0.5 ml undiluted .
$ 1.2 x 10 7 cells.
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FIG. 4 .
￿
Inhibition of specific binding of [9H]DNP-EACA to MOPC 315 cells by increasing
ratio of free to cell surface DNP-binding sites . Inhibition is calculated as in Fig. 2 .
Discussion
The main finding of this study is that immune cells can specifically bind and
retain antigen in the presence of a large excess of specific Ig . This finding
provides a partial explanation for the ability of a small amount of antigen to
stimulate immunocytes in the presence of excess antibody as occurs in secondary
immunization, in the persistent antibody response to slowly catabolized antigen
(11), or after the partial depletion of circulating antibody (2-4) .
In the past we have suggested that antibody regulates its own synthesis
through a feedback mechanism, the central feature of which is a dynamic
equilibrium between circulating antibody and persisting immunogen (1) . In the
presence of large amounts of antibody, which late in the immune response will be
of high affinity, the quantity of available free immunogen will be very small .
Cells must consequently have an advantage over antibody if they are to
effectively interact with antigen. B-cell binding of antigen may be favored by a
number of mechanisms including helper T cells, presentation of antigen on
macrophage surface, and antigen concentration in specific anatomical areas of
lymphoid organs (12) . In addition, cells having multiple binding sites and thus
an effective valence probably much greater than that of circulating antibody,
may be able to bind antigen more avidly than antibody . Theoretical considera-
tions (13) and in vitro experiments (14-18) indicate that multiple bond formation
causes a marked enhancement of binding energy . We have confirmed that these
considerations apply to the binding of antigen by cells . By direct measurement,
the binding affinity of polyvalent antigen to MOPC 315 cells is 100-300 times
greater than that of univalent antigen of similar specificity (5) .
This study allows the competition between specific free Ig and immunocytes
for specific antigen to be expressed quantitatively . Under the conditions of these
experiments, approximately 90 binding sites on free Ig were required per cell
surface binding site to inhibit by 50% specific binding of DNP-BSA. Significant
specific binding still occurred with a 30,000-fold excess of free Ig per cell surfaceJEAN-CLAUDE BYSTRYN, GREGORY W. SISKIND, JONATHAN W. UHR
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binding site or in the presence of 1.25 x 109 molecules of Ig perMOPC 315 cell .
On thebasis of reasonable assumptions it is possible to extend thesenumbers to a
biological framework and demonstrate that cells can effectively capture a small
quantity of antigen administered to an animal with a high concentration of
circulating antibody . If it is assumed that a mouse hyperimmunized to
DNP-BSA has an IgG concentration of 20 mg/ml, that 10% of it is specific
antibody, and that extravascular IgG concentration is 50% that of serum, then it
can be calculated and there will be 3.1 x 10 15 molecules of IgG per ml of
extravascular fluid. If this mouse is boosted with 0.1 mg of DNP-BSA and it is
assumed that the antigen is distributed freely throughout all tissues (density
assumed to be similar to water : 1 g/ml), then the concentration of the antigen in a
30 g mouse will be 3 .3 leg/ml . The concentration of DNP-BSA molecules, based
on a mol wt of 84,000, would be 2.43 x 1013/ml . The ratio of antibody to antigen
molecules will be approximately 100 to 1 . This ratio will be lower if, as is
probable, DNP-BSA does not enter intracellular spaces . In our experiments the
concentration of DNP-BSA was 1 .7 x 10' 2 molecules per ml and that ofMOPC
315 Ig at which specific antigen binding to cell still occurred 1 .4 x 10' 5 molecules
per ml . The ratio of antibody to antigen was approximately 1,000 to 1. Thus,
specific antigen binding to cells occurred in vitro at a lower concentration of
antigen and in the presence of greater excess of antibody than that estimated to
be present in vivo during secondary immunization .
Antigen tends to preferentially localize, and is thus concentrated, in specific
anatomic areas of lymphoid organs, whereas extravascular antibody is in
equilibrium with serum Ig and hence presumably at a similar concentration
throughout the extravascular space . Consequently, the ratio of antibody to
antigen at the actual site of antigen interaction with cells will probably be lower
than that calculated above, shifting the reaction in favor of antigen binding to
cells. The presence in MOPC 315 serum of antibody to myeloma-associated
antigens or to idiotypic determinants on cell surface IgA would not alter these
conclusions. Indeed, by binding to MOPC 315 cells such antibodies might reduce
the effective number of available binding sites forDNP-BSA so that the actual
ability ofMOPC 315 cells to compete for antigen would be even greater than that
observed in these experiments . Nor would the higher binding affinity of antibody
formed late in the immune response in comparison to that ofMOPC 315 alter
these conclusions since it would be matched by a comparable increase in the
binding affinity of cell surface binding sites (19) . In fact, a discrepancy between
the binding affinity of serum antibody and that of binding sites on potential
antibody-forming cells may explain the ability of passive antibody to suppress
the primary antibody response at serum concentrations which do not inhibit the
secondary response (21) . Antibody-mediated suppression is most efficient with
high affinity antibody (20, 21) which will probably bind antigen more effectively
than cells whose binding sites are of low average affinity at the onset of
immunization .
Total and specific antigen binding to cell was time dependent. Prolonged
incubation permitted specific antigen binding to cells in spite of concentrations
of specific Ig which completely inhibited specific binding initially . Thus
equilibrium between antigen, circulating antibody, and specific cells is achieved1234
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slowly in vitro, and perhaps not at all in complex and dynamic in vivo systems .
The rate of reaching equilibrium may play a critical role in influencing the
amount of antigen bound to cells . The effect of free antibody is probably to
reduce the effective free antigen concentration and thus to slow the forward rate
of the reaction of antigen with cell surface binding sites . It is probable that once
antigen interacts with cell surface binding sites multiple bonds are readily
formed as a consequence of the mobility of cell surface Ig, and the probability of
the antigen-cell complex dissociating becomes very low . Thus, one would predict
that if sufficient time were allowed, circulating antibody would actually be very
inefficient in blocking binding of multivalent antigens to cells .
After prolonged incubation with anti-DNP Ig and DNP-BSA, MOPC 315 cells
still bound considerably more of the conjugate than did control myeloma cells .
Furthermore, the rate of increase in DNP-BSA binding was greater toMOPC 315
cells than to control cells . Since both MOPC 315 and control cell suspensions
presumably contain a similar proportion of macrophages, these findings make it
unlikely that cells coated with cytophillic antibody contribute to the greater
binding of DNP-BSA to MOPC 315 as compared to control cells .
Binding of univalent DNP-EACA to cells was inhibited by specific Ig more
readily than that of the multivalent conjugate . Strict comparisons cannot be
made between these experiments, because they could not be performed under
precisely comparable variables . Binding of DNP-BSA and DNP-EACA was
studied at similar concentration of cells, antibody, and DNP groups, but the
molar concentration of DNP-BSA was 23 times less than that of DNP-EACA
(because there were 23 DNP groups per DNP-BSA molecules) . Furthermore,
under the conditions of these assays, boundDNP-BSA occupied 30% of available
binding sites on MOPC 315 cells, whereas DNP-EACA occupied only 7% of
available sites . However, our earlier studies have shown that the binding of
univalent hapten to cells is markedly weaker than that of multivalent ligands of
similar specificity (5) . Binding of univalent hapten to cells was soweak, that 90%
of it could be blocked by physiological concentrations of proteins . These findings
suggest that the arrangement of antigenic determinants into a polyvalent array is
necessary to achieve adequate binding of antigen to cells . Thus, the carrier
requirement for immune response to hapten may be, in part, to present the
hapten in the polyvalent form required for its binding to immunocytes.
These experiments and those of others (5, 22-24) indicate that antigen is
capable of binding nonspecifically to a variety of cells, and that binding is
augmented by aggregation of the antigen into immune complexes by antibody to
the hapten or the carrier . Nonspecific enhancement of antigen binding to cells by
small amounts of antibody may provide a helper mechanism that promotes
immune responses at low antigen concentration by increasing antigen binding to
lymphoid cells and to macrophages . This mechanism would operate in addition
to the antigen-concentrating function provided by specific antigen-binding sites
on B and T cells, and may be mediated by Ig and complement receptors on B
cells and macrophages . This mechanism might be one of the factors contributing
to the augmentation of antibody formation by low doses of passive antibody
(25-27) and the increased antihapten antibody response resulting from preimmu-
nization with carrier (28-30). Finally increased cellular binding of antigenJEAN-CLAUDE BYSTRYN,GREGORY W.SISKIND,JONATHAN W . UHR
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presented as immune complexes would be consistent with mediation of T- and
B-cell cooperation by carrier-specific antibody, a possibility suggested by
Bretscher and Cohn (31) and by Feldmann (32) .
Summary
The effect of specific immunoglobulin (Ig) on specific binding of antigen to cells
has been studied in a model system consisting of murine myeloma cells (MOPC
315), MOPC 315 serum, and DNP conjugates . MOPC 315 serum, which has IgA
specific for DNP, specifically inhibited the binding ofDNP conjugates to these
cells .
Using this model it was found that cells have a marked advantage over free
specific Ig in binding multivalent antigen molecules and retaining them in a
bound state . Cells were able to specifically bind multivalent antigen in the
presence of a large excess of free specific Ig . The kinetics of antigen binding to
cells was slow, and prolongation of time of incubation increased the amount of
specific binding . Both antihapten and anticarrier Ig augmented nonspecific
binding of multivalent but not of univalent hapten to control cells . Furthermore,
antihapten Ig at low concentration increased antigen binding to specific cells .
Received for publication 6 November 1974 .
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